Jazz Pharmaceuticals stockJAZZ
Jazz Pharmaceuticals trades at $227.32, 14.7% below its 52-week high (Aug 25, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +33.7% year to date, +65.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for JAZZ — after you log in
Open the terminalFrequently asked questions about Jazz Pharmaceuticals
What is the Jazz Pharmaceuticals stock price?
At the close on Nov 5, 2026: $227.32 (−3.13% on the day). 52-week high: $266.38 on Aug 25, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Jazz Pharmaceuticals report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed −148% year over year, revenue +10%.
Does Jazz Pharmaceuticals pay dividends?
No, Jazz Pharmaceuticals does not pay dividends.
Where does Jazz Pharmaceuticals trade and how to buy it?
Ticker JAZZ, exchange Nasdaq, listed since 2007. You can buy it through a broker with access to US exchanges.
Should I buy Jazz Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for JAZZ are in the terminal after you log in.